Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea
· Delayed Price · Currency is KRW 244,000
-5,500 (-2.20%)
Mar 11, 2025, 9:00 AM KST
Hanmi Pharm. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 10, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,081,292 | 3,556,800 | 4,473,421 | 3,711,167 | 3,373,870 | 4,397,245 | Upgrade
|
| Market Cap Growth | -20.49% | -20.49% | 20.54% | 10.00% | -23.27% | 25.97% | Upgrade
|
| Enterprise Value | 3,551,538 | 4,027,046 | 4,935,354 | 4,226,778 | 4,030,879 | 5,216,052 | Upgrade
|
| Last Close Price | 243000.00 | 280500.00 | 350901.20 | 290409.65 | 263266.61 | 342142.63 | Upgrade
|
| PE Ratio | 21.47 | 24.79 | 30.59 | 44.83 | 50.34 | 367.69 | Upgrade
|
| Forward PE | 19.19 | 19.54 | 30.57 | 38.01 | 44.63 | 95.75 | Upgrade
|
| PS Ratio | 2.06 | 2.38 | 3.00 | 2.79 | 2.80 | 4.09 | Upgrade
|
| PB Ratio | 2.47 | 2.85 | 4.07 | 3.68 | 3.63 | 5.29 | Upgrade
|
| P/TBV Ratio | 2.85 | 2.85 | 4.92 | 4.50 | 4.47 | 6.44 | Upgrade
|
| P/FCF Ratio | - | - | 23.65 | 28.14 | 18.54 | 40.08 | Upgrade
|
| P/OCF Ratio | - | - | 20.66 | 22.87 | 16.71 | 29.02 | Upgrade
|
| EV/Sales Ratio | 2.37 | 2.69 | 3.31 | 3.17 | 3.35 | 4.85 | Upgrade
|
| EV/EBITDA Ratio | - | - | 15.26 | 16.86 | 18.79 | 47.28 | Upgrade
|
| EV/EBIT Ratio | 16.43 | 18.63 | 21.95 | 27.47 | 32.14 | 106.50 | Upgrade
|
| EV/FCF Ratio | - | - | 26.09 | 32.05 | 22.15 | 47.54 | Upgrade
|
| Debt / Equity Ratio | - | - | 0.52 | 0.67 | 0.81 | 0.96 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 1.77 | 2.71 | 3.53 | 7.27 | Upgrade
|
| Debt / FCF Ratio | - | - | 3.03 | 5.14 | 4.16 | 7.31 | Upgrade
|
| Asset Turnover | 0.76 | 0.76 | 0.78 | 0.69 | 0.63 | 0.57 | Upgrade
|
| Inventory Turnover | - | - | 2.38 | 2.37 | 2.04 | 1.56 | Upgrade
|
| Quick Ratio | - | - | 0.61 | 0.62 | 0.67 | 0.56 | Upgrade
|
| Current Ratio | 1.10 | 1.10 | 1.04 | 1.03 | 1.08 | 1.15 | Upgrade
|
| Return on Equity (ROE) | 12.23% | 12.23% | 15.68% | 10.48% | 9.26% | 2.09% | Upgrade
|
| Return on Assets (ROA) | 6.89% | 6.89% | 7.35% | 4.98% | 4.11% | 1.61% | Upgrade
|
| Return on Capital (ROIC) | 9.26% | 9.26% | 8.36% | 5.70% | 4.72% | 1.85% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.09% | 16.09% | 18.84% | 12.33% | 9.74% | 3.63% | Upgrade
|
| Earnings Yield | 4.66% | 4.03% | 3.27% | 2.23% | 1.99% | 0.27% | Upgrade
|
| FCF Yield | - | 4.23% | 3.55% | 5.39% | 2.50% | Upgrade
| |
| Dividend Yield | 0.20% | - | 0.14% | - | - | - | Upgrade
|
| Payout Ratio | 0.00% | - | 12.31% | 7.24% | 8.77% | 68.07% | Upgrade
|
| Buyback Yield / Dilution | 0.09% | 0.09% | 0.09% | 0.12% | 0.11% | 0.09% | Upgrade
|
| Total Shareholder Return | 0.29% | 0.09% | 0.23% | 0.12% | 0.11% | 0.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.